Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids

Pediatric Pulmonology

Volumn 32, Issue 4, 2001, Pages 338-340

  Kazachkov, Mikhail ^a   Lager, Joanne ^a,b   Lipuma, John ^a   Barker, Pierre M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Burkholderia cepacia; Cepacia syndrome; Corticosteroids; Cystic fibrosis

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; CYTOKINE; METHYLPREDNISOLONE; PIPERACILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BURKHOLDERIA CEPACIA; CASE REPORT; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHOOL CHILD; SEPSIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTEREMIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; METHYLPREDNISOLONE; OPPORTUNISTIC INFECTIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034794999     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1127     Document Type: Article

References (20)

1. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia
2. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak
3. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients
4. Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia
5. Decreased baseline β-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis
6. Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia
7. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
8. Pseudomonas cepacia colonization among patients with cystic fibrosis
9. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis
10. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
11. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis
12. Lower respiratory illness in infants and young children with cystic fibrosis: Evaluation of treatment with intravenous hydrocortisone
13. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
14. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting
15. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products
16. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Sternotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes
17. Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia
18. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia
19. Pseudomonas cepacia - Fatal pulmonary infection in a patient with cystic fibrosis
20. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis